Cargando…

Clinical efficacy and safety of rituximab in lupus nephritis

BACKGROUND: Long-term treatment programs with low toxicity represent a therapeutic challenge in lupus nephritis (LN). Although a therapeutic benefit of rituximab (RTX) has been reported in LN patients who have failed conventional treatment, the results are controversial. We aimed to assess the clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Zhiqing, Li, Hongyan, Zhong, Hongzhen, Zhou, Tianbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417005/ https://www.ncbi.nlm.nih.gov/pubmed/30880917 http://dx.doi.org/10.2147/DDDT.S195113

Ejemplares similares

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
por: Zhong, Hongzhen, et al.
Publicado: (2020)

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
por: Zhong, Hongzhen, et al.
Publicado: (2018)

Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)

Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility
por: Tang, Wenzhuang, et al.
Publicado: (2019)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

A rare case report of heavy dose colchicine induced acute kidney injury
por: Zhong, Hongzhen, et al.
Publicado: (2018)

Association of apoE gene polymorphisms with lipid metabolism in renal diseases
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

A systematic review and meta-analyses of the relationship between glutathione S-transferase gene polymorphisms and renal cell carcinoma susceptibility
por: Zhong, Zhiqing, et al.
Publicado: (2018)

Association of Methylenetetrahydrofolate Reductase, Vitamin D Receptor, and Interleukin-16 Gene Polymorphisms With Renal Cell Carcinoma Risk
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study
por: Abdelkarim Aloub, Khansa Osama, et al.
Publicado: (2022)

Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population
por: Zhou, Tianbiao, et al.
Publicado: (2018)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

Efficacy and safety of rituximab biosimilar in refractory lupus
por: Pongtarakulpanit, Nantakarn, et al.
Publicado: (2020)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Analysis of the safety and efficacy of tacrolimus combined with glucocorticoid in the treatment of lupus nephritis
por: Li, Lu, et al.
Publicado: (2022)

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
por: Cao, Heng, et al.
Publicado: (2015)

Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022)

All-trans retinoic acid regulating angiopoietins-1 and alleviating extracellular matrix accumulation in interstitial fibrosis rats
por: Zhong, Zhiqing, et al.
Publicado: (2021)

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study
por: Vigna-Perez, Mónica, et al.
Publicado: (2006)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility
por: Zhou, Tianbiao, et al.
Publicado: (2018)

Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia
por: Arroyo-Ávila, Mariangelí, et al.
Publicado: (2015)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
por: Zhou, Tianbiao, et al.
Publicado: (2020)

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
por: Wang, Da-Cheng, et al.
Publicado: (2023)

Efficacy and Safety of Biologic Agents for Lupus Nephritis: A Systematic Review and Meta-analysis
por: Chen, Pang, et al.
Publicado: (2023)

Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis
por: Wu, Shanshan, et al.
Publicado: (2020)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Rituximab Used for the Treatment of Nonuremic Calciphylaxis: A Complication of Prolonged Steroid Use in Lupus Nephritis
por: Kahn, Cameron, et al.
Publicado: (2022)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis
por: Alamilla-Sanchez, Mario E, et al.
Publicado: (2021)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
por: Sogayise, Phelisa, et al.
Publicado: (2020)

Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China
por: Tan, Meng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tldc6gurifu46a1qkqbrn2btd4